APD791 clinical trials
Also written APD791 and Temanogrel.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2007
How each study uses APD791 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2021 (2)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2021 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 0
Arena Pharmaceuticals (2) · Pfizer (2) · IlDong Pharmaceutical Co Ltd (2)
Studies
Open first, then newest update. How each study uses APD791 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- A Study to Assess the Effect of Oral Temanogrel on Digital Blood Flow in Adult Participants With Raynaud's Phenomenon Secondary to Systemic SclerosisTerminatedPhase 2PfizerNCT04915950Written as Temanogrel
- A Study Evaluating the Safety, Tolerability, and Effect on Microvascular Obstruction of Intravenous Temanogrel in Adult Participants Undergoing Percutaneous Coronary InterventionTerminatedPhase 2PfizerNCT04848220Written as Temanogrel
- A Multiple-Dose Study to Assess the Safety, Tolerability, and Steady State Pharmacokinetics of APD791 in Healthy VolunteersCompletedPhase 1Arena PharmaceuticalsNCT00619931Written as APD791
- Dose-escalation, Repeated and Single Oral Dosing StudyTerminatedPhase 1IlDong Pharmaceutical Co LtdNCT02419820Written as APD791
- Safety Study of APD-791 With Aspirin and/or ClopidogrelTerminatedPhase 1IlDong Pharmaceutical Co LtdNCT02034292Written as APD791
- Single-Dose Safety Study of APD791 in Healthy VolunteersCompletedPhase 1Arena PharmaceuticalsNCT00529646Written as APD791
Codes
What other systems call APD791 · ClinicalTrials.gg INT005501
- MeSH (NLM) C544126APD791One source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C544126 | APD791 | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.